Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esaxerenone in Japanese subjects with hypertension
NCT02345044Phase 2Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jan 2015
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of esaxerenone in essential hypertension, sponsored by Daiichi Sankyo Co., Ltd.. Started Jan 2015; status: completed.
02
Drugs
esaxerenone
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT02345044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02345044.